LtaS-IN-2
LtaS-IN-2 (compound 13) is a inhibitor of LTA synthesis, and shows antibacterial activity against S. aureus and S. epidermidis, with the MIC90 of 0.5 μg/mL and 1 μg/mL, respectively. LtaS-IN-2 is a derivative of LtaS-IN-1 (HY-135813).
Para uso exclusivo en investigación. No vendemos a pacientes.
- Fòrmula: C24H16F5N3O5S
- Peso molecular:553.46
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
Chemical Information
-
Peso molecular 553.46
-
Fòrmula C24H16F5N3O5S
-
SMILES
O=C(CC1=COC2=CC=C3C=CC=CC3=C21)OCC(NC4=NN=C(O4)C5=CC=C(C=C5)S(F)(F)(F)(F)F)=O
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
[1]. Douglas EJA, Marshall B, Alghamadi A, et al. Improved Antibacterial Activity of 1,3,4-Oxadiazole-Based Compounds That Restrict Staphylococcus aureus Growth Independent of LtaS Function [published online ahead of print, 2023 Oct 13]. ACS Infect Dis. 2023;10.1021/acsinfecdis.3c00250. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)